Nova (NVMI) fell 381 TP3 T from June high despite record quarter — fair value is $357

Despite a record second quarter and upgraded guidance, Nova (NVMI) stock fell 381 TP3T from its June high. This is the result of a combination of tariffs and concerns regarding the late stage of the cycle. The 12-month baseline target price, based on an appropriate multiple of 29x, is $357, and the investment rating is Hold.

All figures in Korean Won were calculated at 1,422 Won per Dollar (as of August 6, 2026), and the market rates and financial data used in the analysis are based on the closing time of the U.S. stock market on August 6.

What kind of company is NVMI?

Nova Ltd. is a semiconductor process control equipment company headquartered in Rehovot, Israel. Founded in 1993, it has 1,612 employees and a market capitalization of $12.1 billion (approximately 17.2 trillion won). Until 2021, its name was Nova Measuring Instruments, and true to its name, it is a "measuring company.".

Semiconductors build hundreds of processes onto a single wafer. With every passing step of lithography, etching, CMP, deposition, and plating, it is necessary to verify whether the linewidth meets the design specifications, the thin film thickness in nanometers, and whether the layers are misaligned. If these measurements are not performed, defects are discovered only dozens of steps later, resulting in the entire wafer lot being discarded. Nova manufactures this measurement equipment and supplies it to logic, foundry, memory, and packaging clients.

Five terms that are helpful to know first

  • Metrology · Process Control — Measuring dimensions and physical properties at various stages of semiconductor manufacturing to correct the process in real time. They sell equipment, but what they are actually selling is the yield.
  • OCD (Optical Critical Dimension Measurement) — A technology that determines the dimensions of invisible nanostructures by shining light on a wafer and inversely calculating the reflection spectrum. It is Nova's flagship technology.
  • Integrated Measurement vs. Standalone — Integrated measurement is a method where the measuring instrument is placed inside the etching or deposition equipment to take measurements during the process, whereas the standalone method involves taking the instrument out as a separate piece of equipment for measurement. Nova is strong in integrated measurement.
  • GAA (Gate All Around) — Transistor structure that becomes fully established starting from the 2-nanometer generation. Because the channel is wrapped around on all sides, the number of measurement points increases rapidly, and the demand for measurement equipment grows accordingly.
  • WFE (Wafer Fabrication Equipment) — A term referring to the entire semiconductor front-end process equipment market. Process control, to which Nova belongs, is a sub-market that accounts for approximately 10 to 121 TP3T of WFE.

What happened in 8 weeks: Record quarter and 381 TP 3 T drop

To understand this stock, you must look at the calendar before the earnings report. This is because events moving in opposite directions have occurred in succession over the past eight weeks.

Point of viewcasestock price
Mid-June 2026Stock hits all-time high on expectations of investment in AI memory and GAA$615.99 (approx. 875,938 won)
July 6thMorgan Stanley raises price target from $494 to $540 (maintains Equal-Weight rating)About $476
July 24thU.S. Takes Effect on Tariffs of $10–$12.51 on 60 Trading Partners; Semiconductor Equipment Stocks Plunge Across the BoardWeekly -11%
Before opening on August 6Q2 Earnings Announcement. Revenue, EPS, and Guidance All Exceeded Consensus.
August 6 closing priceClosed lower despite strong earnings$381.32 (approx. 542,237 KRW, -5.2%)

The stock has fallen 38.11 TP3T from its June high and is 221 TP3T below the 50-day moving average ($488.86). Since the 52-week low is $232.73 (approximately 330,942 KRW), it is not yet in bottoming-out territory. However, the fact that the stock price has fallen while earnings have improved is worth examining in itself.

The following three sentences are the conclusions I reached in this text.

Nova's second quarter of 2026 was a record high with revenue of $255 million (approx. 362.6 billion KRW), an increase of 15.91 TP3T year-over-year, and guidance for the third quarter indicates 25.61 TP3T growth year-over-year.

Nevertheless, the 12-month baseline target price is $357 (approx. 507,654 KRW), which is lower than the current price, and the scenario-weighted expected return is -7.11 TP3T.

The average Wall Street consensus target of $603.38 (approximately 858,006 won) was mostly set in mid-May and has not been updated even after tariffs and a drop of 381 TP3T, and I did not base my writing on this figure.

NVMI Q2 Earnings: Good Numbers, Slightly Deteriorated Quality

The second quarter 2026 (calendar) results, announced on August 6, are superficially flawless. Revenue of $255 million exceeded the consensus of $250.9 million by 1.61 TP3T, and adjusted earnings per share of $2.51 surpassed the consensus of $2.41 by 4.11 TP3T. Adjusted operating profit was $85.25 million, recording an operating profit margin of 33.41 TP3T. Performance compilation dataAccording to [source], this marks the 10th consecutive quarter of sales growth.

The guidance for the third quarter is even better. Revenue is projected at $282 million (approx. 401 billion KRW), exceeding the consensus of $277 million, and adjusted EPS of $2.78 (approx. 3,953 KRW) is also above the consensus of $2.71. Based on the median guidance, the year-over-year growth rate is 25.61 TP3T, which actually accelerates compared to the 15.91 TP3T recorded this quarter. Inventory days decreased from 163 days in the previous quarter to 152 days, 30 days shorter than the five-year average. The fact that inventory has not accumulated is a signal that demand remains alive.

However, the story is a bit different when looking at the quality of earnings. The free cash flow margin fell from 19.51 TP3T in the same period last year to 15.11 TP3T. Looking at the previous quarter's income statement, accounts receivable increased by $25.61 million in a single quarter, and operating cash flow failed to keep pace with net income. The combined net income for the last four quarters is $263.7 million (approximately 375 billion won), while free cash flow stands at around $190 million (approximately 270.2 billion won). While this is a common phenomenon in equipment companies during the growth phase, its nature changes when it appears in the later stages of the cycle.

Gross margins are also quietly declining. Gross margins were 57.71 TP3T in the previous quarter and 57.81 TP3T in the same period last year. While the company explains that this is within the target model range, it also implies that rising component prices and supply chain pressures have begun to be reflected in costs. Demand for 3D NAND remains sluggish, and growth is concentrated in logic, foundry, and advanced packaging.

The financial structure itself is robust. It holds $298.3 million in net cash (approximately 424.2 billion won) with $1.0985 billion in cash equivalents and $800.2 million in total liabilities, and its return on equity is 22.31 TP3T. However, the diluted shares of 34.44 million are 8.31 TP3T higher than the basic shares of 31.79 million. It is natural to assume that the potential conversion of the $750 million in debt raised in the third quarter of 2025 is reflected here.

The channel through which customs duties enter Nova's performance

The tariffs effective on July 24 are the most underestimated variable in this sector. Reported contentAccording to [source], the United States imposed tariffs of 10 to 12.51 TP3T on 60 trading partners based on Section 301 of the Trade Act. The European Union and Taiwan are subject to 101 TP3T, while Japan, South Korea, and Switzerland are subject to 12.51 TP3T. On the day of effective, ASML, KLA, Applied Materials, and Lam Research all fell by 5 to 61 TP3T.

Costs are entering Nova from two directions. First is cost. Although the equipment is assembled in Israel, a significant portion of optical components, precision stages, and control semiconductors are sourced from Japan and Europe. If tariffs are added to component prices, they further dampen the gross margin that is already declining. Second is demand. Nova's sales are concentrated on customers in Taiwan, South Korea, and China; if these clients face tariffs of up to 12.51 TP3T on exports to the U.S., the priorities for fab expansion plans could shift. Equipment orders are a lagging indicator of fab investment decisions.

The important point is that this measure is designed under the Section 301 framework, making it difficult to easily overturn at the discretion of the administration. It is safer to view it as a variable spanning at least several quarters, rather than short-term noise, and reflect it in the model. Adjusted due to the same issue KLA (KLAC) analysisASML AnalysisLooking at them together makes it easier to compare pressure intensity across the equipment sector.

Nova (NVMI) Valuation: The Uncomfortable Gap Between the Fair 29x Multiple and DCF

First, we determine the appropriate multiple. Since using the current multiple directly for the target price leads to circular reasoning that "the current price is correct," we combine the company's historical average with the industry median. Nova's average forward P/E over the past 3 to 5 years is approximately in the 27–28x range, while the median for direct competitors is 29.5x. We mix these two values. Appropriate multiple 29.0xWrites.

itemNova (NVMI)KLA(KLAC)ONTOCamt
Market capitalization17.2 trillion won358.9 trillion won19.0 trillion won9.9 trillion won
Forward PER29.4 times29.5 times27.0 times33.1 times
Price-to-Sales Ratio (TTM)13.4 times18.6 times13.0 times14.0 times
Operating profit margin30.1%42.5%16.8%22.4%
Total margin57.3%61.3%54.2%51.0%
Quarterly Revenue Growth (YoY)+15.9%+15.2%+9.5%+2.5%

Two things can be gleaned from the table. Nova's profitability is clearly higher than Onto and Chemtech, and its growth rate is also ahead. On the other hand, compared to KLA, its operating profit margin is 121 TP3 T points lower, yet its multiple is nearly identical. While this gap is understandable given the differences in economies of scale and the proportion of service revenue, the claim that "Nova is cheaper than KLA" does not hold true at current prices. The smaller scale MKS(MKSI)Teradyne (TER)Even when compared to, it is in the upper-middle range of the multiple spectrum of the equipment sector.

The following is the earnings per share for the next 12 months. Starting from the Q3 guidance of $2.78, assuming Q4 at $2.95, Q1 2027 at $3.05, and Q2 at $3.20, the total comes to $11.98. Considering that the company has exceeded guidance for 10 consecutive quarters, this figure has been slightly raised. $12.30 (approx. 17,491 won)...is used. For reference, the market consensus for the next fiscal year's EPS is $12.97 (approximately 18,443 won), which is more aggressive than this.

Dividing the current price of $381.32 by the next 12-month EPS yields a multiple of 31.0x. This is compared to the fair multiple of 29.0x. 6.9% PremiumIt is not extremely overvalued, and compared to the June peak (around 45x forward), it has normalized considerably.

DCF indicates a much lower value.

DCF assumptionreason
Weighted Average Cost of Capital (WACC)10.5~11.0%Beta 1.778, risk-free rate in the 41TP/3T range, net cash structure
End-of-life growth rate3.0%Long-term GDP + Inflation
forecast period5 years / 10 yearsTwo cases in parallel due to low cycle visibility
Standard free cash flow$190 million (normalized $250 million)TTM Performance and Working Capital Normalization Assumptions
Calculated fair price range$160–$2405-year case bottom, 10-year case top

The DCF results deviate significantly from the multiple approach. There are three reasons for this. First, due to a beta of 1.778, the cost of equity rises to the 131 TP 3T range, making the discount rate heavy. Second, free cash flow remains at the 721 TP 3T level of net income, resulting in a cash-based value that is lower than the accounting income-based value. Third, the 5-year forecast structurally underestimates the value of high-growth companies. Therefore, I do not use DCF directly in calculating the target price. For checking safety marginsIt is written only as. However, the fact that the current price is 59% higher than the upper limit of the DCF does not make the valuation judgment “fair” OvervaluedIt serves as the basis for determining it.

NVMI Target Price Scenarios and 1-Year Expected Return

Let's start by summarizing the growth rate assumptions. If we weight the past 5-year average annual revenue growth rate of 23.41 TP3T, the market consensus growth rate for the next 12 months of 29.31 TP3T, and the long-term growth rate of the process control industry of approximately 121 TP3T by 0.4, 0.4, and 0.2, respectively... 23.51 TP3T per year...is released. It is not significantly different from the 25.61 TP3T growth for the third quarter announced by the company.

scenarioTarget priceKorean Won ConversionCompared to the current priceweightKey assumptions
stress$457649,854 won+19.8%22%Resumption of 3D NAND investment, securing tariff exemptions, revaluation of forwards at 33x
basic$357507,654 won-6.4%50%EPS $12.30 × Fair multiple 29.0x
Weakness$268381,096 won-29.7%28%End of upcycle, EPS retreats to $11 range, multiple narrows to 24x

The reason for setting the weights at 50, 22, and 28 is clear. Since the premium is 6.91 TP3T, which is not extreme, the base scenario was set to half; however, the bearish weight was increased over the bullish weight because three signals overlapped: ① this is the end of the usual upcycle length (8–10 quarters) with 10 consecutive quarters of growth, ② tariffs are acting on both cost and demand, and ③ the DCF indicates a value much lower than the current price.

The weighted expected value is $354.08, compared to the current price of $381.32. The expected rate of return is -7.11 TP3TC. The range from -8% to +12% in the decision band is a Hold. The fact that it is close to the boundary line itself summarizes the current position of this stock well.

NVMI Investment Risks and Bear Triggers

I organized it based on what makes this stock a sell.

  • Upcycling ends → Since equipment orders lag fab investment decisions by 6 to 12 months, if orders decline, revenue drops sharply two or three quarters later. → Monitoring indicators: Quarterly order backlog, revisions to annual capital expenditure guidance for TSMC, Samsung Electronics, and SK Hynix.
  • Further decline in total margin → If tariffs and component prices continue to be reflected in costs, operating leverage acts in the opposite direction, causing EPS estimates to fluctuate. → Monitoring indicators: Whether quarterly gross margin falls below 571 TP3T, and whether adjusted operating profit margin is maintained at 331 TP3T.
  • Customer Concentration and Geopolitics → Sales are concentrated on a small number of customers in Taiwan, Korea, and China, and the headquarters is located in Israel. Export restrictions or deterioration of regional conditions are immediately reflected in supply and sales. → Monitoring indicators: Proportion of sales to China, changes in U.S. equipment export restrictions to China.
  • Dilution → The diluted number of shares is 8.31 TP3T higher than the base number of shares. If the conversion actually occurs, the per-share indicator will be diluted by that amount. → Monitoring indicator: Quarterly trend of diluted shares.

Conversely, the bullish trigger is 3D NAND. Currently, NAND-related demand is sluggish, but if this sector recovers, demand for integrated measurement, where Nova is strong, will increase along with it. The direction of the memory cycle is Lam Research (LRCX) AnalysisIt becomes easier to judge when viewed together with the order flow of etching and deposition equipment discussed earlier.

Stories outside the data

The number I spent the longest time looking at this quarter was not revenue or EPS, but the free cash flow margin. It fell from 19.51 TP3T to 15.11 TP3T, yet inventory days actually improved. It was accounts receivable, not inventory, that increased. This means that equipment has been shipped but the money has not yet come in, a phenomenon that naturally occurs when demand is strong. However, I always become cautious when I see the combination of "revenue at an all-time high, but cash not coming in as much" in the latter part of the cycle. This is because the income statements just before the peak of the equipment cycle in 2018 and 2022 looked exactly like this.

One more point. The Wall Street average target price of $603 is based on the figures of eight analysts, five of which were established immediately after the first-quarter earnings on May 14–15. Since then, despite tariffs on July 24 and a drop of 381 TP 3 T, the target prices have remained virtually unchanged. It is rather telling that Morgan Stanley was the only firm to update its target price in July at $540 with an "Equal-Weight" rating. I do not base my investment decisions on unupdated target prices. Finally, regarding the nature of the position, Nova possesses one of the highest-quality business models in the equipment sector, but it is a stock with a market capitalization of 17 trillion KRW, coverage by eight analysts, and a beta of 1.78. I believe it is more suited as a satellite bet on the semiconductor cycle rather than a core position.

Investment Conclusion: Hold, but confidence is not high

I will summarize in one paragraph the signals that led to this opinion. Although the current premium of 6.91 TP3T relative to the fair multiple of 29.0x is not large, the scenario-weighted expected return is -7.11 TP3T, which is hovering at the lower end of the Hold band; furthermore, the DCF indicates a value significantly lower than the current price; and the upcycle is in its tenth quarter, marking the statistical tail end. The key point is that while fundamentals are clearly improving, that improvement is already reflected in the price. Therefore Hold, moderate confidenceam.

The consensus is Strong Buy (1.5) and the average target price is $603.38. The difference from my conclusion stems from the timing of the target price calculation and the multiples applied. The consensus target price is calculated by applying approximately 46 times to the next fiscal year's EPS of $12.97, a multiple that Nova has never maintained except during the overheated phase in the first half of 2026. I applied 29 times to the same EPS.

In practice, the summary is as follows. If you already hold the stock, hold it until the Q3 earnings confirm the maintenance of a gross margin of 571 TP3T and the order flow, but defer additional purchases. If considering a new entry, waiting for a correction to the $320 range (around 26x forward) offers better risk-to-reward. You should consider selling when the gross margin falls below 571 TP3T or when Q4 guidance drops below 201 TP3T year-over-year. The original documents disclosed by the company are Nova IR PageIt can be checked at, and past performance trends are Stock Data PageIt is well organized.

Frequently Asked Questions

What is the 12-month target price for Nova (NVMI)?

The baseline target price for this analysis is $357 (approximately 507,654 KRW). This is based on applying an appropriate multiple of 29.0x to a 12-month EPS of $12.30. The target is bullish at $457 and bearish at $268, with a weighted expected return of -7.11 TP3T and a Hold rating. The market consensus average target price is much higher at $603.38, but most of those figures have not been updated since mid-May.

Why did the stock price fall when earnings exceeded the consensus?

Three factors overlapped. First, the sales outperformance was 1.61 TP3T, which was smaller than the company's usual surprises. Second, as the free cash flow margin fell from 19.51 TP3T to 15.11 TP3T, questions arose regarding the quality of earnings. Third, the strong individual earnings could not be absorbed as the entire semiconductor equipment sector is undergoing a correction following the tariffs on July 24. However, it rebounded by 2.31 TP3T in after-hours trading.

Is the valuation right to enter now?

The forward P/E ratio of 29.4x has dropped significantly from around 45x at the June high and is nearly equal to the industry median of 29.5x. In other words, it is difficult to say that it is “abnormally expensive.” However, since a premium of 6.91 TP3T remains relative to the fair multiple and the DCF indicates a much lower value, this article assesses that it is better to wait until the price reaches the $320 range, corresponding to a P/E ratio of 26x, to secure a margin of safety.

What is Nova's biggest bearish trigger?

The upcycle has ended. This quarter marks the 10th consecutive quarter of growth, whereas semiconductor upcycles typically last 8 to 10 quarters. Since equipment orders lag behind fab investment decisions, a downward revision of capital expenditure guidance by major customers is reflected in revenue two or three quarters later. In practice, a quarterly gross margin falling below 571 TP3T, or a next-quarter guidance growth rate falling below 201 TP3T, is viewed as a warning signal.

Where does Nova's competitiveness lie compared to KLA and Onto?

Nova's strength lies in its integrated measurement capabilities. Since the measuring instrument is placed inside the etching and deposition equipment rather than as a separate unit to perform measurements during the process, real-time correction is possible without loss of throughput. Its profitability is also 30.11 TP3T, which is higher than Onto (operating profit margin 16.81 TP3T) and Camtech (22.41 TP3T). On the other hand, compared to KLA (42.51 TP3T), it lags behind in scale and the proportion of service revenue, yet its multiple is nearly identical, so it does not offer significant appeal as a relative undervaluation.

References


This analysis is for informational purposes only. AI research tools were utilized during the preparation process, and the author personally reviewed the figures and logic prior to publication. Stock price, exchange rate, and earnings estimates are based on data as of August 6, 2026, and are subject to change thereafter; the investor bears sole responsibility for investment decisions and their outcomes.